article · British Journal of Cancer · 1986
The effect of folate supplements on 6-mercaptopurine remission maintenance therapy in childhood leukaemia
Lynne Lennard, J S Lilleyman, John L. Maddocks
Cited by 33Open access
Abstract
The index has no abstract for this paper. The publisher’s page may have one.
Cite this paper
Lennard, L., Lilleyman, J. S., & Maddocks, J. L. (1986). The effect of folate supplements on 6-mercaptopurine remission maintenance therapy in childhood leukaemia. British Journal of Cancer, 53(1), 115–119. https://doi.org/10.1038/bjc.1986.16
Lennard, Lynne, et al. “The effect of folate supplements on 6-mercaptopurine remission maintenance therapy in childhood leukaemia.” British Journal of Cancer, vol. 53, no. 1, 1986, pp. 115–19, https://doi.org/10.1038/bjc.1986.16.
Lennard, Lynne, J S Lilleyman, and John L. Maddocks. 1986. “The effect of folate supplements on 6-mercaptopurine remission maintenance therapy in childhood leukaemia.” British Journal of Cancer 53 (1): 115–19. https://doi.org/10.1038/bjc.1986.16.
Lennard, L., Lilleyman, J.S. and Maddocks, J.L. (1986) ‘The effect of folate supplements on 6-mercaptopurine remission maintenance therapy in childhood leukaemia’, British Journal of Cancer, 53(1), pp. 115–119. Available at: https://doi.org/10.1038/bjc.1986.16.
@article{lennard1986effect,
title = {{The effect of folate supplements on 6-mercaptopurine remission maintenance therapy in childhood leukaemia}},
author = {Lennard, Lynne and Lilleyman, J S and Maddocks, John L.},
journal = {British Journal of Cancer},
volume = {53},
number = {1},
pages = {115--119},
year = {1986},
doi = {10.1038/bjc.1986.16}
}Made from the index record. Check names, capitalisation and page numbers against the paper. Need another style? AI for Research has over 10,000.
Related papers
Folic Acid Supplements in Vitamin Tablets: A Determinant of Hematological Drug Tolerance in Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia
Henrik Daa Schrøder, Niels Clausen, Erik Øtergård et al. · Pediatric Hematology and Oncology · 1986
Cited by 26
Childhood leukaemia: a relationship between intracellular 6‐ mercaptopurine metabolites and neutropenia.
Lynne Lennard, Corinne Rees, JS Lilleyman et al. · British Journal of Clinical Pharmacology · 1983
Cited by 167Open access
Folate deficiency in north Indian children undergoing maintenance chemotherapy for acute lymphoblastic leukemia—Implications and outcome
Nirmalya Roy Moulik, Archana Kumar, Suraksha Agrawal et al. · Pediatric Blood & Cancer · 2017
Cited by 16
6-Thioguanine nucleotide accumulation in red blood cells during maintenance chemotherapy for childhood acute lymphoblastic leukemia, and its relation to leukopenia
Kjeld Schmiegelow, Ivan Bruunshuus · Cancer Chemotherapy and Pharmacology · 1990
Cited by 45
Pharmacokinetics of 6-Thioguanine and 6-Mercaptopurine Combination Maintenance Therapy of Childhood ALL: Hypothesis and Case Report
Stine Nygaard Nielsen, Thomas Leth Frandsen, Jacob Nersting et al. · Journal of Pediatric Hematology/Oncology · 2014
Cited by 3
First clinical experience with 6 Mercaptopurine powder for oral suspension PREVALLTM for maintenance therapy in Pediatric Acute lymphoblastic leukemia
Chetan Anil Dhamne, Rangasai Anirudh Neeli, Naman Agrawal et al. · 2026
Cited by 0
Toxic complications of treatment with 6-mercaptopurine in pediatric acute lymphoblastic leukemia
Shaymaa A. Temraz, FaridaH Rashidy, SehamM Ragab et al. · Menoufia Medical Journal · 2015
Cited by 8
Mercaptopurine metabolite levels are predictors of bone marrow toxicity following high-dose methotrexate therapy of childhood acute lymphoblastic leukaemia
Sophia Ingeborg Vang, Kjeld Schmiegelow, Thomas Leth Frandsen et al. · Cancer Chemotherapy and Pharmacology · 2015
Cited by 20